p53 codon 72 polymorphism, loss of heterozygosity and high-risk human papillomavirus infection in a low-incidence German esophageal squamous cell carcinoma patient cohort

Oncology Reports

Volumn 17, Issue 5, 2007, Pages 1243-1248

  Pantelis, Annette ^a   Pantelis, Dimitrios ^a   Ruemmele, Petra ^b   Hartmann, Arndt ^b   Hofstaedter, Ferdinand ^b   Buettner, Reinhard ^a   Bootz, Friedrich ^a   Stoehr, Robert ^b  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Esophageal squamous cell carcinoma; Human papillomavirus infection; Loss of heterozygosity; p53 codon 72 polymorphism

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CODON; COHORT ANALYSIS; ESOPHAGUS TUMOR; FEMALE; GENETIC POLYMORPHISM; GENETICS; GERMANY; HETEROZYGOSITY LOSS; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; PATHOLOGY; RISK FACTOR; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; VIROLOGY; VIRUS INFECTION;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CODON; COHORT STUDIES; DNA, VIRAL; ESOPHAGEAL NEOPLASMS; FEMALE; GENES, P53; GERMANY; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 34548554110     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.5.1243     Document Type: Article

References (34)

1. An JY, Fan ZM, Gao SS, Zhuang ZH, Qin YR, Li JL, He X and Wang LD: Loss of heterozygosity in multistage carcinogenesis of esophageal carcinoma at high-incidence area in Henan Province, China. World J Gastroenterol 11: 2055-2060, 2005. (Pubitemid 40542646)
2. Crew KD and Neugut AI: Epidemiology of upper gastrointestinal malignancies. Semin Oncol 31: 450-464, 2004. (Pubitemid 39070265)
3. Dumont P, Leu JI, Della Pietra AC III, George DL and Murphy M: The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33: 357-365, 2003. (Pubitemid 36278852)
4. Kawajiri K, Nakachi K, Imai K, Watanabe J and Hayashi S: Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer. Carcinogenesis 14: 1085-1089, 1993. (Pubitemid 23193532)
5. Wang YC, Chen CY, Chen SK, Chang YY and Lin P: p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis. Clin Cancer Res 5: 129-134, 1999.
6. Murata M, Tagawa M, Kimura M, Kimura H, Watanabe S and Saisho H: Analysis of a germ line polymorphism of the p53 gene in lung cancer patients; discrete results with smoking history. Carcinogenesis 17: 261-264, 1996. (Pubitemid 26091303)
7. Thiagalingam S, Foy RL, Cheng KH, Lee HJ, Thiagalingam A and Ponte JF: Loss of heterozygosity as a predictor to map tumor suppressor genes in cancer: molecular basis of its occurrence. Curr Opin Oncol 14: 65-72, 2002. (Pubitemid 34072966)
8. Cullis CA: The use of DNA polymorphisms in genetic mapping. Genet Eng 24: 179-189, 2002.
9. Kawaguchi H, Ohno S, Araki K, Miyazaki M, Saeki H, Watanabe M, Tanaka S and Sugimachi K: p53 polymorphism in human papillomavirus-associated esophageal cancer. Cancer Res 60: 2753-2755, 2000. (Pubitemid 30395785)
10. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuer J, Leigh IM, Matlashewski G and Banks L: Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer. Nature 393: 229-234, 1998. (Pubitemid 28261713)
11. Turner JR, Shen LH, Crum CP, Dean PJ and Odze RD: Low prevalence of human papillomavirus infection in esophageal squamous cell carcinomas from North America: analysis by a highly sensitive and specific polymerase chain reaction-based approach. Hum Pathol 28: 174-178, 1997. (Pubitemid 27069182)
12. Kamath AM, Wu TT, Heitmiller R, Daniel R and Shah KV: Investigation of the association of esophageal carcinoma with human papillomaviruses. Dis Esophagus 13: 122-124, 2000.
13. Li T, Lu ZM, Guo M, Wu QJ, Chen KN, Xing HP, Mei Q and Ke Y: p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus-associated carcinomas in China. Cancer 95: 2571-2576, 2002. (Pubitemid 35424044)
14. Scheffner M, Werness BA, Huibregtse JM, Levine AJ and Howley PM: The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129-1136, 1990. (Pubitemid 120035062)
15. Sobin LH and Wittekind C: TNM Classification of Malignant Tumors. 6th edition. Wiley-Liss, New York, 2002.
16. Schlegel J, Bocker T, Zirngibl H, Hofstaedter F and Ruschoff J: Detection of microsatellite instability in human colorectal carcinomas using a non-radioactive PCR-based screening technique. Virchows Arch 426: 223-227, 1995.
17. Toh Y, Kuwano H, Tanaka S, Baba K, Matsuda H, Sugimachi K and Mori R: Detection of human papillomavirus DNA in esophageal carcinoma in Japan by polymerase chain reaction. Cancer 70: 2234-2238, 1992.
18. Mandard AM, Hainaut P and Hollstein M: Genetic steps in the development of squamous cell carcinoma of the esophagus. Mutat Res 462: 335-342, 2000. (Pubitemid 30190239)
19. He D, Zhang DK, Lam KY, Ma L, Ngan HY, Liu SS and Tsao SW: Prevalence of HPV infection in esophageal squamous cell carcinoma in Chinese patients and its relationship to the p53 gene mutation. Int J Cancer 72: 959-964, 1997. (Pubitemid 27433558)
20. Cao W, Chen X, Dai H, Wang H, Shen B, Chu D, McAfee T and Zhang ZF: Mutational spectra of p53 in geographically localized esophageal squamous cell carcinoma groups in China. Cancer 101: 834-844, 2004. (Pubitemid 39030942)
21. Putz A, Hartmann AA, Fontes PR, Alexandre CO, Silveira DA, Klug SJ and Rabes HM: TP53 mutation pattern of esophageal squamous cell carcinomas in a high risk area (Southern Brazil): role of life style factors. Int J Cancer 98: 99-105, 2002. (Pubitemid 34113425)
22. Aoki T, Mori T, Du X, Nishira T, Matsubara T and Nakamura Y: Allelotype study of esophageal carcinoma. Genes Chromosomes Cancer 10: 177-182, 1994. (Pubitemid 24198755)
23. Shibagaki I, Shimada Y, Wagata T, Ikenaga M, Imamura M and Ishizaki K: Allelotype analysis of esophageal squamous cell carcinoma. Cancer Res 54: 2996-3000, 1994. (Pubitemid 24187786)
24. Hu N, Huang J, Emmert-Buck MR, Tang ZZ, Roth MJ, Wang C, Dawsey SM, Li G, Li WJ, Wang QH, Han XY, Ding T, Giffen C, Goldstein AM and Taylor PR: Frequent inactivation of the TP53 gene in esophageal squamous cell carcinoma from a high-risk population in China. Clin Cancer Res 7: 883-891, 2001. (Pubitemid 32708725)
25. Awerkiew S, Bollschweiler E, Metzger R, Schneider PM, Hölscher AH and Pfister H: Esophageal cancer in Germany is associated with Epstein-Barr-virus but not with papillomaviruses. Med Microbiol Immunol 192: 137-140, 2003. (Pubitemid 37100657)
26. Awerkiew S, Hausen AZ, Baldus SE, Holscher AH, Sidorenko SI, Kutsev SI and Pfister HJ: Presence of Epstein-Barr virus in esophageal cancer is restricted to tumor infiltrating lymphocytes. Med Microbiol Immunol 194: 187-191, 2005. (Pubitemid 41159452)
27. Jenkins TD, Nakagawa H and Rustgi AK: The association of Epstein-Barr virus DNA with esophageal squamous cell carcinoma. Oncogene 13: 1809-1813, 1996. (Pubitemid 26377514)
28. Lyronis ID, Baritaki S, Bizakis I, Tsardi M and Spandidos DA: Evaluation of the prevalence of human papillomavirus and Epstein-Barr virus in esophageal squamous cell carcinomas. Int J Biol Markers 20: 5-10, 2005. (Pubitemid 40667594)
29. Sunpaweravong S, Mitarnum W and Puttawibul P: Absence of Epstein-Barr virus in esophageal squamous cell carcinoma. Dis Esophagus 18: 398-399, 2005. (Pubitemid 43904768)
30. Chen WC, Tsai FJ, Wu JY, Wu HC, Lu HF and Li CW: Distributions of p53 codon 72 polymorphism in bladder cancer - proline form is prominent in invasive tumor. Urol Res 28: 293-296, 2000.
31. Vos M, Adams CH, Victor TC and van Helden PD: Polymorphisms and mutations found in the regions flanking exon 5 to 8 of the TP53 gene in a population at high risk for esophageal cancer in South Africa. Cancer Genet Cytogenet 140: 23-30, 2003. (Pubitemid 36110635)
32. Shen H, Liu Z, Strom SS, Spitz MR, Lee JE, Gershenwald JE, Ross MI, Mansfield PE, Duvic M, Ananthaswamy HN and Wei Q: p53 codon 72 Arg homozygotes are associated with an increased risk of cutaneous melanoma. J Invest Dermatol 121: 1510-1514, 2003. (Pubitemid 38005506)
33. Szymanowska A, Jassem E, Dziadziuszko R, Borg A, Limon J, Kobierska-Gulida G, Rzyman W and Jassem J: Increased risk of non-small lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism. Lung Cancer 52: 9-14, 2006. (Pubitemid 43340193)
34. Scheckenbach K, Lieven O, Götte K, Bockmühl U, Zotz R, Bier H and Balz V: p53 codon 72 polymorphic variants, loss of allele-specific transcription, and human papilloma virus 16 and/or 18 E6 messenger RNA expression in squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Rev 13: 1805-1809, 2004. (Pubitemid 39482960)